Squarepoint’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $493K | Buy |
145,051
+102,047
| +237% | +$347K | ﹤0.01% | 1923 |
|
|
2025
Q1 | $172K | Sell |
43,004
-24,911
| -37% | -$99.9K | ﹤0.01% | 2408 |
|
|
2024
Q4 | $441K | Sell |
67,915
-42,666
| -39% | -$277K | ﹤0.01% | 1998 |
|
|
2024
Q3 | $613K | Sell |
110,581
-76,780
| -41% | -$425K | ﹤0.01% | 1649 |
|
|
2024
Q2 | $1.05M | Buy |
187,361
+170,539
| +1,014% | +$952K | ﹤0.01% | 1350 |
|
|
2024
Q1 | $113K | Buy |
+16,822
| New | +$113K | ﹤0.01% | 2235 |
|
|
2023
Q2 | – | Sell |
-30,773
| Closed | -$283K | – | 2464 |
|
|
2023
Q1 | $283K | Sell |
30,773
-54,660
| -64% | -$502K | ﹤0.01% | 1708 |
|
|
2022
Q4 | $872K | Buy |
+85,433
| New | +$872K | ﹤0.01% | 1167 |
|